Press release -

Changes to the Board of Directors of Chr. Hansen Holding A/S

On March 16, Henrik Poulsen and Alice Dautry were appointed new members of the Board of Chr. Hansen Holding A/S. At the same time Lennart Holm, PAI partners, stepped down.

In order to further strengthen the company, Chr. Hansen Holding A/S has named two new members to its board of directors:


Henrik Poulsen [born 1967] has served as the Chief Executive Officer (CEO) of TDC A/S since November 2008 and holds a M.Sc. in Finance and Accounting from Aarhus School of Business. He has had significant experience in strategic planning and execution as a result of senior positions in companies such as McKinsey & Co., LEGO A/S and KKR Capstone, and these capabilities will prove valuable to the board.
Alice Dautry [born 1950] has served as President of the Institut Pasteur a world leading research institute in microbiology since 2005 and has a strong scientific profile within immune health and microbiology. Prof. Dautry trained as a solid state physicist at the University of Paris and as a molecular biologist at the University of New York at Stony Brook and the National Institutes of Health in Maryland. Alice Dautry will bring a strong scientific background in the field of Health and Nutrition to the board.


The present Chr. Hansen Board of Directors consists of: Ole Andersen (chairman), Frédéric Stévenin (vice-chairman), Alice Dautry, Gaëlle d’Engremont, Malene Lunddal Hansen, Svend Laulund, Henrik Poulsen, Martin Seidel and Lionel Zinsou.

For further information on this release, please contact:

Ole Andersen, Chairman
Tel.: +45 4574 7623

Kristine Ahrensbach, Corporate Communications
Tel.: +45 2249 5115

Topics

Chr. Hansen is a global bioscience company that develops natural ingredient solutions for the food, nutritional, pharmaceutical and agricultural industries. The products include cultures, enzymes, probiotics and natural colors, and all solutions are based on strong research and development competencies coupled with significant technology investments. Revenue in the 2013/14 financial year was EUR 756 million. The company holds a leading market position in all its divisions: Cultures & Enzymes, Health & Nutrition and Natural Colors. It has more than 2,500 dedicated employees in over 30 countries and main production facilities in Denmark, France, USA and Germany. Chr. Hansen was founded in 1874 and is listed on NASDAQ OMX Copenhagen.

Contacts

Helle Rexen

Helle Rexen

Press contact Media relations officer +45 20 74 28 40

About us

Chr. Hansen is a global, differentiated bioscience company that develops natural ingredient solutions for the food, nutritional, pharmaceutical and agricultural industries. At Chr. Hansen we are uniquely positioned to drive positive change through microbial solutions. We have worked for over 150 years to enable sustainable agriculture, better food and healthier living for more people around the world. Our microbial and fermentation technology platforms, including our broad and relevant collection of around 50,000 microbial strains, have game-changing potential. Matching customer needs and global trends we continue to unlock the power of good bacteria to respond to global challenges such as food waste, global health and the overuse of antibiotics and pesticides. As one of the world’s most sustainable companies, we touch the lives of more than 1 billion people every day. Driven by our legacy of innovation and curiosity to pioneer science, our purpose – To grow a better world. Naturally. – is at the heart of everything we do.

Chr. Hansen Holding A/S

Boege Allé 10-12
DK-2970 Hoersholm
Denmark

Chr. Hansen website
Investor Relations
Read more about Chr. Hansen
Enter your email address to follow Chr. Hansen Holding A/S

When you choose to create a user account and follow a newsroom your personal data will be used by us and the owner of the newsroom, for you to receive news and updates according to your subscription settings.

To learn more about this, please read our Privacy Policy, which applies to our use of your personal data, and our Privacy Policy for Contacts, which applies to the use of your personal data by the owner of the newsroom you follow.

Please note that our Terms of Use apply to all use of our services.

You can withdraw your consent at any time by unsubscribing or deleting your account.
Check your inbox

Email sent to __email__. Click the link there to follow Chr. Hansen Holding A/S.

Okay